Equities

Nath Bio-Genes (I) Ltd

NATHBIOGEN:NSI

Nath Bio-Genes (I) Ltd

Actions
Consumer Staples Food Producers
  • Price (INR)201.80
  • Today's Change-2.35 / -1.15%
  • Shares traded27.63k
  • 1 Year change+20.12%
  • Beta1.8440
Data delayed at least 15 minutes, as of May 03 2024 11:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nath Bio-Genes (India) Limited is an India-based formidable seed company, which is focused on developing and supplying BT, hybrid and varietal seeds to farmers. The Company is engaged in the Seed Cultivation segment. The Company’s products categories include oilseeds and fiber, field crops, vegetables and plant nutrition. Its fiber and oils seeds include cotton and mustard. The Company's vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber, coriander, pumpkin, tinda and others. Its field corps include corn, jowar, hybrid paddy, research paddy and wheat. Its plant nutrition products include WINPro GOLii, WINall and Win Chin Win. Its forage products include NUTRIMAX and NUTRIMAX GOLD. The Company has seed processing facilities processing plants located in Maharashtra, Telangana and Andhra Pradesh. The Company also has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis.

  • Revenue in INR (TTM)3.35bn
  • Net income in INR378.62m
  • Incorporated1993
  • Employees433.00
  • Location
    Nath Bio-Genes (I) LtdNath House, Nath Road, P.No.518MUMBAI 400020IndiaIND
  • Phone+91 2 222871001
  • Fax+91 2 222875652
  • Websitehttps://nathbiogenes.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dhunseri Tea & Industries Ltd3.91bn-1.00bn2.11bn13.17k------0.5401-95.47-95.47371.99--------296,800.80--0.2607--0.297693.9265.49-25.670.8282---9.59--115.11-3.313.2974.76--54.46-10.87
Upsurge Seeds Of Agriculture Ltd-100.00bn-100.00bn2.13bn--------------------------------------------------20.80--364.71------
ShreeOswal Seeds and Chemicals Ltd-100.00bn-100.00bn2.79bn----------------------------4.80--12.16--6.73--2.25--------13.2372.424.9838.60----
Harrisons Malayalam Limited4.65bn26.95m3.38bn7.35k124.78--42.370.72741.471.47251.61--------632,733.30--3.30--6.0970.7958.920.57943.09--0.5207----3.234.89-23.0531.9138.86--
UMA Exports Ltd15.64bn101.36m3.48bn33.0034.20--32.810.22253.013.01466.68--------473,800,000.00--7.72--19.396.349.460.64831.63--2.06--0.0016.3331.0515.9951.7077.97--
Nath Bio-Genes (I) Ltd3.35bn378.62m3.84bn433.0010.18--9.321.1519.8321.14175.79--------7,726,892.00--3.13--4.0766.8359.6611.328.03--5.07--6.778.269.48151.993.54-12.11--
Data as of May 03 2024. Currency figures normalised to Nath Bio-Genes (I) Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

4.61%Per cent of shares held by top holders
HolderShares% Held
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 30 Jun 2023875.71k4.61%
Data from 15 Apr 2024 - 15 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.